Delivery Order 36F79721D0019-36C24826F0044
- Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., was awarded a $324,059 delivery order by Veterans Integrated Service Network 2 on October 23, 2025, for the provision of Decipher Prostate Cancer testing services at the Northport Veterans Affairs Medical Center. The contract, which is not set aside for any specific business category, is structured as a firm fixed-price delivery order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule...
- Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., received a $648,118 delivery order from Veterans Integrated Service Network 10 (VISN 10) for the Decipher Prostate Testing service at locations in Ann Arbor, Saginaw, and Battle Creek, Michigan, with completion expected by November 14, 2030. This non-set-aside contract, awarded on November 15, 2025, is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and represents work...
- This delivery order, awarded to Veracyte Labs SD Corporation (a division of Decipher Biosciences, Inc.) on April 15, 2023, represents Option Year 2 of a contract to provide Decipher Prostate Testing services to Veterans Integrated Service Network 10 (VISN 10). The contract, valued at $408,314.34 on a firm fixed-price basis, will be performed in Ann Arbor, Michigan, with an ultimate completion date of November 14, 2025. This award was not subject to any small business set-aside and is established...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostics company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16). The contract is for $405,018.00 and involves the provision of genomic testing services, specifically Veracyte's proprietary genomic testing products and services. This is a firm fixed-price purchase order contract with a period of performance ending on May 31, 2029. The contract is not set aside and appears to...
- This federal contract award is for TESTING SERVICES- LAB provided by Veracyte Labs SD Corporation, a subsidiary of Veracyte, Inc. The contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) and does not have a set-aside designation. The contract, valued at $272,209.56, is a Delivery Order under Veracyte's existing Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services (FSS-621-II). Through this award, Veracyte...
- This federal contract award, valued at $184,713.63, was made by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract is for the provision of the Decipher Prostate Cancer Test, a specialized genomic classifier that analyzes tumor gene expression patterns to help clinicians make more informed treatment decisions for prostate cancer patients. The contract is a Blanket Purchase...
- This is a $84,000.00 firm fixed-price Delivery Order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a for-profit corporate entity specializing in advanced genomic testing services for medical diagnostics. The contract provides reference laboratory services for VISN 23. This award is not set-aside for any specific business category. Veracyte holds several significant Indefinite Delivery Vehicle (IDV) contracts with the VA and...
- This is a firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract, valued at $372,667.85, is for the delivery of the Decipher Prostate Cancer Test, a specialized genomic diagnostic service that analyzes tumor gene expression patterns to help clinicians assess prostate cancer risk and guide treatment decisions. The contract is a Blanket Purchase Agreement...
- This is a federal contract award to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., for DECIPHER PROSTATE CANCER TESTING services. The contract, valued at $3,240.59, was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA). This is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does...
- This is a federal contract award issued by the Veterans Integrated Service Network 1 (VISN 1), which is part of the U.S. Department of Veterans Affairs (VA), to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is for $300,000.00 and involves the provision of prostate cancer genomic testing and analysis services through a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II)...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- 36F79721D0019Federal Supply Schedule
- 36F79721D0019-36C24826F0044Delivery Order
Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., was awarded a delivery order valued at $1.62M by Veterans Integrated Service Network 8 on December 1, 2025, for genomic sequencing classifier services under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract, which carries a firm fixed price and no set-aside designation, extends through November 30, 2030, with performance taking place at Bay Pines, Florida. This delivery order leverages Veracyte's established blanket purchase agreement with VISN 8 valued at $972,177 and reflects the company's specialized capabilities in precision cancer diagnostics, particularly its proprietary Decipher Prostate Cancer Test for analyzing tumor gene expression patterns. The Department of Veterans Affairs' Veterans Integrated Service Network 8, which serves veterans across the Gulf Coast region, continues to utilize Veracyte's advanced molecular diagnostic services to support precision medicine initiatives within its healthcare systems. This award demonstrates the ongoing partnership between the VA and Veracyte for providing genomic testing that enables clinicians to assess cancer risk and aggressiveness, supporting more informed treatment decision-making for veteran populations. Veracyte maintains similar contract vehicles across multiple VISN regions and the Defense Health Agency, positioning itself as a key provider of specialized genomic testing services throughout the federal healthcare sector.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $324.1k | 11/12/25 |